For this study, Best Practices engaged 22 leaders from 16 biopharmaceutical companies and two medical device and health care firms through a benchmarking survey.
Only a third of participants in the study said they had seen slight or great improvement of call quality since deploying iPads to MSLs; 57% said call quality has stayed the same.
A majority of study participants said there had been an increase in the number of scientific presentations delivered since the deployment of iPads to MSLs, according to the study.
Best Practices serves biopharmaceutical and medical device companies worldwide. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis.
Novocure announces presentation of new TTFields research at EANO and ESMO 2025 meetings
OSR Holdings to acquire Korean non-invasive glucose monitor developer Woori IO
Autonomix Medical secures new US patent to expand precision nerve-targeted therapies
MedHub-AI's AutocathFFR receives national reimbursement approval in Japan
Microbot Medical secures first Japanese patent for Liberty robotic system following FDA clearance
Polarean Imaging signs new supply agreementwith UVA Health for clinical Xenon MRI
Femasys partners with Kebomed to expand FemBloc permanent birth control in France and Benelux
Implantica receives positive FDA feedback on final RefluxStop PMA submission
Tempus secures FDA clearance for RNA-based xR IVD diagnostic device
Shoulder Innovations expands I-Series portfolio with launch of InSet 70 Humeral Stem
GSK commits USD30bn to US R&D and manufacturing expansion
ArtPlayer Promotes Elderly Wellbeing with Digital Signage and Streaming Art in Finnish Care Homes
Implantica produces 10,000 RefluxStop units ahead of planned US launch